Showing results (131-140 of 266) with videos related to

Sort By:
Pageof 27
Psychopharmacology|March 1, 1978
Clinical and plasma level characteristics of intramuscular and oral loxapineG M Simpson, T B Cooper, J H Lee, et al.
Psychopharmacology|April 11, 1979
Effects of loxapine on the sleep of chronic schizophrenicsM H Branchey, D R Brebbia, T B Cooper, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 1, 1989
Steady state pharmacokinetics of nortriptyline in the frail elderlyI R Katz, G M Simpson, V Jethanandani, et al.
The Journal of Clinical Psychiatry|June 1, 1986
Anticholinergic agents for prophylaxis of neuroleptic-induced dystonic reactions: a prospective studyJ J Sramek, G M Simpson, R L Morrison, et al.
The Journal of Clinical Psychiatry|June 20, 2001
The apparent effects of ziprasidone on plasma lipids and glucoseS J Kingsbury, M Fayek, D Trufasiu, et al.
The American Journal of Psychiatry|August 1, 1978
Evaluation of a slow-release lithium carbonate formulationT B Cooper, G M Simpson, J H Lee, et al.
Archives of General Psychiatry|July 1, 1975
Butaperazine pharmacokinetics. Effect of dosage regimen on steady state blood levelsT B Cooper, G M Simpson, E F Haher, et al.
The Journal of Clinical Psychiatry|March 1, 1988
Plasma levels and therapeutic response with trimipramine treatment of endogenous depressionG M Simpson, E H Pi, L Gross, et al.
Neuropeptides|October 1, 1988
Characterization of human placental opioid receptors by 3H-ethylketocyclazocine and 3H-naloxone bindingA Agbas, J Simon, H Avni Oktem, et al.
Die Pharmazie|June 16, 1999
Nonspecific membrane effects of CH-103: hydrophobicity, surface activity and membrane fluidity studies in comparison with propranolol and practololE Varga, J Szöllösi, K Antal, et al.
Pageof 27